| SCHEDULE OF INFORMATION RELATED TO OPERATIONS OF REPORTABLE OPERATING SEGMENTS |
Information
related to the operations of the Company’s reportable operating segments is set forth below:
SCHEDULE
OF INFORMATION RELATED TO OPERATIONS OF REPORTABLE OPERATING SEGMENTS
| | |
Pathogen
prevention | | |
Global
warming solutions | | |
Total | |
| Nine months ended September 30, 2024 | |
| | | |
| | | |
| | |
| Revenues | |
| 69,481 | | |
| - | | |
| 69,481 | |
| Operating loss | |
| (830,372 | ) | |
| (250,698 | ) | |
| (1,081,070 | ) |
| Unallocated amounts: | |
| | | |
| | | |
| | |
| Unallocated costs | |
| | | |
| | | |
| (2,223,999 | ) |
| Total operating loss | |
| | | |
| | | |
| (3,315,069 | ) |
| Financing expenses, net | |
| | | |
| | | |
| (117,335 | ) |
| Other income | |
| | | |
| | | |
| 353,033 | |
| Changes in fair value of an investment in an associate measured under the
fair value option | |
| | | |
| | | |
| (856,836 | ) |
| Net loss | |
| | | |
| | | |
| (3,936,207 | ) |
| | |
Pathogen
prevention | | |
Global
warming solutions | | |
Total | |
| Three months ended September 30, 2024 | |
| | | |
| | | |
| | |
| Revenues | |
| 9,104 | | |
| - | | |
| 9,104 | |
| Operating loss | |
| (355,811 | ) | |
| (113,948 | ) | |
| (469,759 | ) |
| Unallocated amounts: | |
| | | |
| | | |
| | |
| Unallocated costs | |
| | | |
| | | |
| (1,080,036 | ) |
| Total operating loss | |
| | | |
| | | |
| (1,549,795 | ) |
| Financing expenses, net | |
| | | |
| | | |
| (41,215 | ) |
| Other income | |
| | | |
| | | |
| 247,808 | |
| Changes in fair value of an investment in an associate measured under the
fair value option | |
| | | |
| | | |
| (970,505 | ) |
| Net loss | |
| | | |
| | | |
| (2,313,707 | ) |
| | |
Pathogen
prevention | | |
Global
warming solutions | | |
Total | |
| Nine months ended September 30, 2023 | |
| | | |
| | | |
| | |
| Revenues | |
| 157,618 | | |
| - | | |
| 157,618 | |
| Operating loss | |
| (915,374 | ) | |
| (1,675,505 | ) | |
| (2,590,879 | ) |
| Unallocated amounts: | |
| | | |
| | | |
| | |
| Unallocated costs | |
| | | |
| | | |
| (2,850,017 | ) |
| Total operating loss | |
| | | |
| | | |
| (5,440,896 | ) |
| Financing income, net | |
| | | |
| | | |
| 43,666 | |
| Other income | |
| | | |
| | | |
| 12,294 | |
| Changes in fair value of an investment in an associate measured under the fair
value option | |
| | | |
| | | |
| (87,576 | ) |
| Net loss | |
| | | |
| | | |
| (5,472,512 | ) |
| | |
Pathogen
prevention | | |
Global
warming solutions | | |
Total | |
| Three months ended September 30, 2023 | |
| | | |
| | | |
| | |
| Revenues | |
| - | | |
| - | | |
| - | |
| Operating loss | |
| (303,487 | ) | |
| (1,675,505 | ) | |
| (1,978,992 | ) |
| Unallocated amounts: | |
| | | |
| | | |
| | |
| Unallocated costs | |
| | | |
| | | |
| (877,932 | ) |
| Total operating loss | |
| | | |
| | | |
| (2,856,924 | ) |
| Financing income, net | |
| | | |
| | | |
| 10,579 | |
| Other income | |
| | | |
| | | |
| - | |
| Changes in fair value of an investment in an associate measured under the fair
value option | |
| | | |
| | | |
| (189,683 | ) |
| Net loss | |
| | | |
| | | |
| (3,036,028 | ) |
|
Information
related to the operations of the Company’s reportable operating segments is set forth below:
SCHEDULE
OF SEGMENT REPORTING PROFIT AND LOSS
| | |
Pathogen
prevention | | |
Global
warming solutions | |
|
Total | |
| Year
ended December 31, 2023 | |
| | | |
| | |
|
| | |
| Revenues | |
| 263,445 | | |
| - | |
|
| 263,445 | |
| Operating
loss | |
| (1,098,383 | ) | |
| (1,788,093 | ) |
|
| (2,886,476 | ) |
| Unallocated
amounts: | |
| | | |
| | |
|
| | |
| Unallocated
costs | |
| | | |
| | |
|
| (4,691,300 | ) |
| Total
operating loss | |
| | | |
| | |
|
| (7,577,776 | ) |
| Financing
income, net | |
| | | |
| | |
|
| 46,511 | |
| Other
income | |
| | | |
| | |
|
| 984,940 | |
| Changes
in fair value of an investment in an associate measured under the fair value option | |
| | | |
| | |
|
| (713,593 | ) |
| Net
loss | |
| | | |
| | |
|
| (7,259,918 | ) |
|
| SCHEDULE OF INFORMATION ON SALES BY GEOGRAPHIC DISTRIBUTION |
Sales
are attributed to geographic distribution based on the location of the customer.
SCHEDULE
OF INFORMATION ON SALES BY GEOGRAPHIC DISTRIBUTION
| | |
2024 | | |
2023 | | |
2024 | | |
2023 | |
| | |
Nine months ended September 30, | | |
Three months ended September 30, | |
| | |
2024 | | |
2023 | | |
2024 | | |
2023 | |
| | |
| | |
| | |
| | |
| |
| Israel | |
| 27,629 | | |
| 5,221 | | |
| 8,326 | | |
| - | |
| United States | |
| 39,752 | | |
| 41,554 | | |
| 778 | | |
| - | |
| Mexico | |
| - | | |
| 109,824 | | |
| - | | |
| - | |
| Peru | |
| 2,100 | | |
| - | | |
| - | | |
| - | |
| Turkey | |
| - | | |
| 1,019 | | |
| - | | |
| - | |
| Revenues
from sales | |
| 69,481 | | |
| 157,618 | | |
| 9,104 | | |
| - | |
|
Sales
are attributed to geographic distribution based on the location of the customer.
SCHEDULE
OF INFORMATION ON SALES BY GEOGRAPHIC DISTRIBUTION
| | |
2023 | | |
2022 | |
| | |
Year
ended December 31 | |
| | |
2023 | | |
2022 | |
| | |
| | |
| |
| United
States | |
| 142,733 | | |
| 163,644 | |
| Mexico | |
| 109,824 | | |
| 154,425 | |
| Israel | |
| 9,869 | | |
| 29,998 | |
| Turkey | |
| 1,019 | | |
| 45,937 | |
| Revenues
from sales of products | |
| 263,445 | | |
| 394,004 | |
|
| SCHEDULE OF SALES TO CUSTOMERS |
SCHEDULE
OF SALES TO CUSTOMERS
| | |
2024 | | |
2023 | | |
2024 | | |
2023 | |
| | |
Nine months ended September 30, | | |
Three months ended September 30, | |
| | |
2024 | | |
2023 | | |
2024 | | |
2023 | |
| | |
| | |
| | |
| | |
| |
| Customer A | |
| - | | |
| 109,824 | | |
| - | | |
| - | |
| Customer B | |
| 38,974 | | |
| 41,554 | | |
| - | | |
| - | |
| Customer C | |
| 16,946 | | |
| - | | |
| 3,911 | | |
| - | |
| Revenues
from sales | |
| 55,920 | | |
| 151,378 | | |
| 3,911 | | |
| - | |
|
SCHEDULE
OF SALES TO CUSTOMERS
| | |
2023 | | |
2022 | |
| | |
Year
ended December 31 | |
| | |
2023 | | |
2022 | |
| | |
| | |
| |
| Customer
A | |
| 142,733 | | |
| 163,644 | |
| Customer
B | |
| 109,824 | | |
| 154,425 | |
| Customer
C | |
| - | | |
| 45,937 | |
| Revenues
from sales of products | |
| 252,557 | | |
| 364,006 | |
|
| SCHEDULE OF INFORMATION ON LONG LIVED ASSETS |
The
following table presents the locations of the Company’s long-lived assets as of September 30, 2024 and December 31, 2023:
SCHEDULE
OF INFORMATION ON LONG LIVED ASSETS
| | |
As of September 30, | | |
As of December 31, | |
| | |
2024 | | |
2023 | |
| | |
| | |
| |
| Israel | |
| 53,555 | | |
| 102,103 | |
| United States | |
| 15,085 | | |
| 21,046 | |
| Property,
plant and equipment and ROU assets | |
| 68,640 | | |
| 123,149 | |
|
The
following table presents the locations of the Company’s long-lived assets as of December 31, 2023 and 2022:
SCHEDULE
OF INFORMATION ON LONG LIVED ASSETS
| | |
2023 | | |
2022 | |
| | |
Year
ended December 31 | |
| | |
2023 | | |
2022 | |
| | |
| | |
| |
| Israel | |
| 102,103 | | |
| 207,779 | |
| United
States | |
| 21,046 | | |
| 11,990 | |
| Property,
plant and equipment and ROU assets | |
| 123,149 | | |
| 219,769 | |
|